+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

The effect of surgery on the serum concentration of CA125 in epithelial ovarian cancer



The effect of surgery on the serum concentration of CA125 in epithelial ovarian cancer



Annals of Clinical Biochemistry 30: 402-403




(PDF emailed within 0-6 h: $19.90)

Accession: 033784688

Download citation: RISBibTeXText

PMID: 8379653

DOI: 10.1177/000456329303000409



Related references

Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer. International Journal of Gynecological Cancer 18(4): 621-628, 2007

Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors. Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177, 1985

Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer. Journal of Ovarian Research 9(1): 61-61, 2016

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study. Gynecologic Oncology 104(3): 508-515, 2006

The cost effectiveness of serum ca125 monitoring in epithelial ovarian cancer. British Journal of Cancer 61(1): 178, 1990

Early serum CA125 response and outcome in epithelial ovarian cancer. European Journal of Cancer 26(5): 593-596, 1990

Preoperative serum CA125 in surgical stage 1 epithelial ovarian cancer. Gynecologic Oncology 107(2): 357-358, 2007

Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer. British Journal of Obstetrics & Gynaecology 101(10): 888-893, 1994

Serum CA125 assay in the early diagnosis of recurrent epithelial ovarian cancer. Oncology Reports 3(2): 301-303, 1996

Differential expression of CA125 and a novel serum tumor marker HE4 in epithelial ovarian cancer. Journal of Clinical Oncology 26(15_suppl): 5533-5533, 2016

Serum measurements of CA125, CA19-9, CA15-3 and TAG-72 in patients with epithelial ovarian cancer. Anticancer Research 13(5B): 1660-1663, 1993

Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: comparison with CA125. Clinical Biochemistry 26(3): 213-219, 1993

Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer. Medicine 97(16): E0358-E0358, 2018

Factors predictive of elevated serum CA125 levels in patients with epithelial ovarian cancer. Bulletin du Cancer 94(7): E18-E22, 2007

Serum CA125 in combination with ferritin improves diagnostic accuracy for epithelial ovarian cancer. British Journal of Biomedical Science: 1-5, 2018